Case Study: Mid-Atlantic Health System achieves early drug-diversion detection and reduced harm with Imprivata FairWarning Drug Diversion Intelligence

Mid-Atlantic health system takes proactive approach to drug diversion monitoring with Imprivata FairWarning Drug Diversion Intelligence

One of the largest health systems in the Mid‑Atlantic (12,000 employees) faced a critical patient- and staff-safety issue after an internal Fentanyl diversion by a trusted nurse. The incident spurred the creation of a system‑wide drug diversion prevention committee and a mandate to implement proactive monitoring to detect diversion early, protect patients and staff, and reduce organizational and regulatory risk.

After evaluating three vendors, the system adopted Imprivata FairWarning Drug Diversion Intelligence — leveraging ADC data analytics plus a dedicated FairWarning drug diversion analyst — to identify behavioral trends that signal diversion. The program enabled early detection of two diversion incidents, strengthened documentation and policy adherence, extended the health system’s investigative capacity, reduced diversion‑related risk, and improved overall compliance and confidence in oversight.